Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, T De Baere, L Kulik, PK Haber… - Nature reviews …, 2021 - nature.com
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Gut and liver, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations

JC Nault, O Sutter, P Nahon, N Ganne-Carrié… - Journal of …, 2018 - Elsevier
Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

[PDF][PDF] Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial

ZW Peng, YJ Zhang, MS Chen, L Xu, HH Liang… - Journal of clinical …, 2013 - Citeseer
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the
Treatment of Hepatocellular Carcinoma: A Page 1 Radiofrequency Ablation With or Without …

Hepatocellular carcinoma: current management and perspectives for the future

NN Rahbari, A Mehrabi, NM Mollberg, SA Müller… - Annals of …, 2011 - journals.lww.com
Objective: To review the literature on current management of hepatocellular carcinoma
(HCC). Background: Hepatocellular carcinoma represents one of the most common …

Local-regional treatment of hepatocellular carcinoma

R Lencioni, L Crocetti - Radiology, 2012 - pubs.rsna.org
Local-regional treatments play a key role in the management of hepatocellular carcinoma
(HCC). Image-guided tumor ablation is recommended in patients with early-stage HCC …

Insufficient radiofrequency ablation promotes hepatocellular carcinoma metastasis through N6‐methyladenosine mRNA methylation‐dependent mechanism

T Su, M Huang, J Liao, S Lin, P Yu, J Yang, Y Cai… - …, 2021 - Wiley Online Library
Background and Aims The dynamic N6‐methyladenosine (m6A) mRNA modification is
essential for acute stress response and cancer progression. Sublethal heat stress from …

Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma

JH Wang, CC Wang, CH Hung, CL Chen, SN Lu - Journal of hepatology, 2012 - Elsevier
BACKGROUND & AIMS: To compare the survival between surgical resection (SR) and
radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) in Barcelona …

The 10-year survival analysis of radiofrequency ablation for solitary hepatocellular carcinoma 5 cm or smaller: primary versus recurrent HCC

XM Bai, M Cui, W Yang, H Wang, S Wang, ZY Zhang… - Radiology, 2021 - pubs.rsna.org
Background Although favorable outcomes have been reported with radiofrequency ablation
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …

Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective …

ZW Peng, YJ Zhang, HH Liang, XJ Lin, RP Guo… - Radiology, 2012 - pubs.rsna.org
Purpose To compare prospectively the effects of radiofrequency (RF) ablation after
transcatheter arterial chemoembolization (TACE) with those of RF ablation alone in the …